The Latest Breaking News on Pharma

The synthetic biology pioneer has underpromised and over-delivered on biosecurity revenue in 2022. Here's what comes next.

The biotech industry thrived during the pandemic. However, that seems to be fading as the pandemic situation has relaxed. And given the inherent volatility of penny stocks, iBio (IBIO), VistaGen Therapeutics (VTGN), and Timber Pharmaceuticals (TMBR) might be best avoided amid the broader market turmoil. Read more….

Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.

Some Australians are waiting longer than ever to see their GP, and one state has come up with a possible solution that would allow pharmacists to take over some of the doctors' prescription work. But a trial that was due to begin in June has now been delayed, with no…

Thai Leaf Biotechnology, a private company that imports and produces hemp seed, in collaboration with Cornell University, has unveiled plans to upgrade the Thai hemp market by developing new strains of hemp and seeds that are suitable to be grown in Thailand's climate as well as yielding a high cannabidiol…

Congo's health ministry has confirmed a new Ebola case in Congo’s eastern Beni city and say it was linked to a previous outbreak

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

Bed Bath & Beyond (NASDAQ: BBBY) traders learned last week about Jake Freeman, the 20-year University of Southern California student investor who outsmarted the entire class of "Ape" investors, including GameStop Corp. (NYSE:

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.